Global Viral Vector Development Service Market Report 2021
- Category: Business & Services
- Published Date: Aug 2021
- Publisher: DK Report
- Pages: 110
The Viral Vector Development Service market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Segment by Type
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Others Viral Vectors
Segment by Application
Pharmaceutical Manufacturers
Biotechnology Companies
Research Institutes
The Viral Vector Development Service market is analysed and market size information is provided by regions (countries). Segment by Application, the Viral Vector Development Service market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
UJIFILM Diosynth Biotechnologies
Sanofi
Spark Therapeutics
UniQure
MassBiologics
FinVector
Thermo Fisher Scientific (Brammer Bio)
Cell and Gene Therapy Catapult
Cobra Biologics
Segment by Type
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Others Viral Vectors
Segment by Application
Pharmaceutical Manufacturers
Biotechnology Companies
Research Institutes
The Viral Vector Development Service market is analysed and market size information is provided by regions (countries). Segment by Application, the Viral Vector Development Service market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
UJIFILM Diosynth Biotechnologies
Sanofi
Spark Therapeutics
UniQure
MassBiologics
FinVector
Thermo Fisher Scientific (Brammer Bio)
Cell and Gene Therapy Catapult
Cobra Biologics
1. Introduction
1.1 Objective of the Study
1.1.1 Market Definition
1.2. Market Scope
1.3. Years Considered
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.2. Market Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top down Approach
2.2.3. Annual Turnover Process
2.3. Research Assumptions
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Industry Trends
5.1 Introduction
5.2 Value Chain Analysis
5.3 Porter’s Five Forces Analysis
5.3.1 Political
5.3.2 Economical
5.3.3 Social
5.3.4 Technological
5.3.5 Environmental
5.3.6 Legal
6. Global Viral Vector Development Service Market, By End-User
6.1.Retroviral Vectors
6.2.Lentiviral Vectors
6.3.Adenoviral Vectors
6.4.Adeno-associated Viral Vectors
6.5.Others Viral Vectors
7. Viral Vector Development Service Market Overview, By Indication
7.1.Pharmaceutical Manufacturers
7.2.Biotechnology Companies
7.3.Research Institutes
8. Geographical Analysis
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. RoE
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. RoAPAC
8.5. RoW
8.5.1. Latin America
8.5.1.1. Brazil
8.5.1.2. Argentina
8.5.1.3. Rest of Latin America
8.5.2. Middle East and Africa
9. Company Profiles
9.1.UJIFILM Diosynth Biotechnologies
9.2.Sanofi
9.3.Spark Therapeutics
9.4.UniQure
9.5.MassBiologics
9.6.FinVector
9.7.Thermo Fisher Scientific (Brammer Bio)
9.8.Cell and Gene Therapy Catapult
9.9.Cobra Biologics
10. Disclaimer
1.1 Objective of the Study
1.1.1 Market Definition
1.2. Market Scope
1.3. Years Considered
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.2. Market Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top down Approach
2.2.3. Annual Turnover Process
2.3. Research Assumptions
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Industry Trends
5.1 Introduction
5.2 Value Chain Analysis
5.3 Porter’s Five Forces Analysis
5.3.1 Political
5.3.2 Economical
5.3.3 Social
5.3.4 Technological
5.3.5 Environmental
5.3.6 Legal
6. Global Viral Vector Development Service Market, By End-User
6.1.Retroviral Vectors
6.2.Lentiviral Vectors
6.3.Adenoviral Vectors
6.4.Adeno-associated Viral Vectors
6.5.Others Viral Vectors
7. Viral Vector Development Service Market Overview, By Indication
7.1.Pharmaceutical Manufacturers
7.2.Biotechnology Companies
7.3.Research Institutes
8. Geographical Analysis
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. RoE
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. RoAPAC
8.5. RoW
8.5.1. Latin America
8.5.1.1. Brazil
8.5.1.2. Argentina
8.5.1.3. Rest of Latin America
8.5.2. Middle East and Africa
9. Company Profiles
9.1.UJIFILM Diosynth Biotechnologies
9.2.Sanofi
9.3.Spark Therapeutics
9.4.UniQure
9.5.MassBiologics
9.6.FinVector
9.7.Thermo Fisher Scientific (Brammer Bio)
9.8.Cell and Gene Therapy Catapult
9.9.Cobra Biologics
10. Disclaimer
no record found